Harrow (HROW) Treasury Shares (2012 - 2025)
Harrow's (HROW) quarterly Treasury Shares came in at $214212.0 in Q4 2025, down 39.34% year-on-year from $353112.0 in Q4 2024, and down 83.46% quarter-over-quarter from $1.3 million in Q3 2025.
Harrow (HROW) Treasury Shares (2012 - 2025) Analysis & Trends
Harrow's Treasury Shares history runs 14 years deep, the most recent figure standing at $214212.0 for Q4 2025.
- On a quarterly basis, Treasury Shares fell 39.34% year-over-year to $214212.0 in Q4 2025; TTM through Dec 2025 was $214212.0, a 39.34% decrease from a year earlier, with the FY2025 full-year figure at $214212.0, down 39.34% from the prior year.
- Treasury Shares slipped to $214212.0 in Q4 2025 per HROW's latest filing, from $1.3 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.2 billion in Q3 2021 and bottomed at $214212.0 in Q4 2025.
- The 5-year median for Treasury Shares is $1.6 million (2024), against an average of $113.4 million.
- Across the five-year window, Treasury Shares soared 138839.17% in 2021 and plunged 99.91% in 2022, its largest moves.
- Year by year, Treasury Shares stood at $665288.0 in 2021, then decreased by 25.78% to $493806.0 in 2022, then retreated by 26.48% to $363029.0 in 2023, then decreased by 2.73% to $353112.0 in 2024, then plunged by 39.34% to $214212.0 in 2025.
- Per Business Quant, the three latest HROW Treasury Shares figures stand at $214212.0 (Q4 2025), $1.3 million (Q3 2025), and $342039.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 214,212.00 |
| Dec 31, 2025 | 214,212.00 |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 342,039.00 |
| Jun 30, 2025 | 342,039.00 |
| Mar 31, 2025 | 1.57 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 353,112.00 |
| Dec 31, 2024 | 353,112.00 |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 363,029.00 |
| Dec 31, 2023 | 363,029.00 |
| Sep 30, 2023 | 305,977.00 |
| Sep 30, 2023 | 305,977.00 |